| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0016500 | Exon-Exon | chr3:171965323-172013304 | chr3:172247533-172295514 | 244 nt | 0.5164 |
| hsa_FNDC3B_0016600 | Exon-Exon | chr3:171965323-172025291 | chr3:172247533-172307501 | 244 nt | 0.5164 |
| hsa_FNDC3B_0016000 | Exon-Exon | chr3:171965323-172062048 | chr3:172247533-172344258 | 1986 nt | 0.4955 |
| hsa_FNDC3B_0015600 | Exon-Exon | chr3:171965323-172070873 | chr3:172247533-172353083 | 2531 nt | 0.4966 |
| hsa_FNDC3B_0015700 | Exon-Exon | chr3:171965323-172080635 | chr3:172247533-172362845 | 2744 nt | 0.4942 |
| hsa_FNDC3B_0016700 | Exon-Exon | chr3:171965323-172098883 | chr3:172247533-172381093 | 128 nt | 0.4063 |
| hsa_chr3_0367100 | Intergenic-Intergenic | chr3:171965418-171969077 | chr3:172247628-172251287 | 177 nt | 0.4463 |
| hsa_FNDC3B_0018000 | Exon-Exon | chr3:171969050-172003774 | chr3:172251260-172285984 | 341 nt | 0.4809 |
| hsa_FNDC3B_0018100 | Exon-Exon | chr3:171969050-172013304 | chr3:172251260-172295514 | 152 nt | 0.4737 |
| hsa_FNDC3B_0017800 | Intron-Exon-Intron | chr3:171969050-172018859 | chr3:172251260-172301069 | 2835 nt | 0.3760 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].